US20180014936A1 - Bioactive material - Google Patents
Bioactive material Download PDFInfo
- Publication number
- US20180014936A1 US20180014936A1 US15/680,757 US201715680757A US2018014936A1 US 20180014936 A1 US20180014936 A1 US 20180014936A1 US 201715680757 A US201715680757 A US 201715680757A US 2018014936 A1 US2018014936 A1 US 2018014936A1
- Authority
- US
- United States
- Prior art keywords
- primary layer
- surface area
- implant
- layer
- substrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000463 material Substances 0.000 title claims abstract description 43
- 230000000975 bioactive effect Effects 0.000 title abstract description 5
- 239000007943 implant Substances 0.000 claims abstract description 47
- 238000000034 method Methods 0.000 claims abstract description 15
- 239000010410 layer Substances 0.000 claims description 119
- 239000000758 substrate Substances 0.000 claims description 64
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims description 42
- 239000003513 alkali Substances 0.000 claims description 41
- 239000010936 titanium Substances 0.000 claims description 34
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 33
- 229910052719 titanium Inorganic materials 0.000 claims description 30
- 229910001069 Ti alloy Inorganic materials 0.000 claims description 27
- 239000012670 alkaline solution Substances 0.000 claims description 15
- 238000002791 soaking Methods 0.000 claims description 15
- 239000002086 nanomaterial Substances 0.000 claims description 13
- 239000002344 surface layer Substances 0.000 claims description 11
- GROMGGTZECPEKN-UHFFFAOYSA-N sodium metatitanate Chemical compound [Na+].[Na+].[O-][Ti](=O)O[Ti](=O)O[Ti]([O-])=O GROMGGTZECPEKN-UHFFFAOYSA-N 0.000 claims description 6
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 claims description 5
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 claims description 5
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 4
- 229910052588 hydroxylapatite Inorganic materials 0.000 claims description 4
- 210000000988 bone and bone Anatomy 0.000 abstract description 18
- 239000000316 bone substitute Substances 0.000 abstract description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical group [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 81
- 238000001878 scanning electron micrograph Methods 0.000 description 27
- 239000002245 particle Substances 0.000 description 23
- 239000000243 solution Substances 0.000 description 19
- 238000005422 blasting Methods 0.000 description 18
- 101100468275 Caenorhabditis elegans rep-1 gene Proteins 0.000 description 15
- 101100238610 Mus musculus Msh3 gene Proteins 0.000 description 15
- 238000011282 treatment Methods 0.000 description 13
- 229910045601 alloy Inorganic materials 0.000 description 10
- 239000000956 alloy Substances 0.000 description 10
- 239000006260 foam Substances 0.000 description 10
- 238000004458 analytical method Methods 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 9
- 238000004626 scanning electron microscopy Methods 0.000 description 9
- 125000003821 2-(trimethylsilyl)ethoxymethyl group Chemical group [H]C([H])([H])[Si](C([H])([H])[H])(C([H])([H])[H])C([H])([H])C(OC([H])([H])[*])([H])[H] 0.000 description 8
- 239000011324 bead Substances 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 8
- 238000005755 formation reaction Methods 0.000 description 8
- 229910052751 metal Inorganic materials 0.000 description 6
- 239000002184 metal Substances 0.000 description 5
- 230000002188 osteogenic effect Effects 0.000 description 5
- 238000012876 topography Methods 0.000 description 5
- 239000004053 dental implant Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 4
- 230000010354 integration Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 3
- 239000004568 cement Substances 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 229910001092 metal group alloy Inorganic materials 0.000 description 3
- 238000002203 pretreatment Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 229910052726 zirconium Inorganic materials 0.000 description 3
- 229910000684 Cobalt-chrome Inorganic materials 0.000 description 2
- 229910000791 Oxinium Inorganic materials 0.000 description 2
- 229910000883 Ti6Al4V Inorganic materials 0.000 description 2
- -1 TiAlNb Chemical compound 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 238000007743 anodising Methods 0.000 description 2
- 239000002639 bone cement Substances 0.000 description 2
- 239000010952 cobalt-chrome Substances 0.000 description 2
- 238000005336 cracking Methods 0.000 description 2
- 230000032798 delamination Effects 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 230000011164 ossification Effects 0.000 description 2
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 2
- 238000007750 plasma spraying Methods 0.000 description 2
- 238000005488 sandblasting Methods 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 229910052723 transition metal Inorganic materials 0.000 description 2
- 150000003624 transition metals Chemical class 0.000 description 2
- 229910001928 zirconium oxide Inorganic materials 0.000 description 2
- BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 229920000914 Metallic fiber Polymers 0.000 description 1
- 208000003076 Osteolysis Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000003416 augmentation Effects 0.000 description 1
- 239000000337 buffer salt Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000002559 cytogenic effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 208000020089 femoral neck fracture Diseases 0.000 description 1
- 210000002436 femur neck Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 210000004394 hip joint Anatomy 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 150000008040 ionic compounds Chemical class 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 208000029791 lytic metastatic bone lesion Diseases 0.000 description 1
- 238000003754 machining Methods 0.000 description 1
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 1
- 229910000000 metal hydroxide Inorganic materials 0.000 description 1
- 150000004692 metal hydroxides Chemical class 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 1
- 229910001000 nickel titanium Inorganic materials 0.000 description 1
- 230000000278 osteoconductive effect Effects 0.000 description 1
- 230000002138 osteoinductive effect Effects 0.000 description 1
- SOQBVABWOPYFQZ-UHFFFAOYSA-N oxygen(2-);titanium(4+) Chemical class [O-2].[O-2].[Ti+4] SOQBVABWOPYFQZ-UHFFFAOYSA-N 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000000323 shoulder joint Anatomy 0.000 description 1
- 231100001055 skeletal defect Toxicity 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- VEALVRVVWBQVSL-UHFFFAOYSA-N strontium titanate Chemical compound [Sr+2].[O-][Ti]([O-])=O VEALVRVVWBQVSL-UHFFFAOYSA-N 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 229910052715 tantalum Inorganic materials 0.000 description 1
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 1
- 229910000314 transition metal oxide Inorganic materials 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/28—Bones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/04—Metals or alloys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/30—Inorganic materials
- A61L27/306—Other specific inorganic materials not covered by A61L27/303 - A61L27/32
-
- C—CHEMISTRY; METALLURGY
- C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
- C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
- C23C22/00—Chemical surface treatment of metallic material by reaction of the surface with a reactive liquid, leaving reaction products of surface material in the coating, e.g. conversion coatings, passivation of metals
- C23C22/05—Chemical surface treatment of metallic material by reaction of the surface with a reactive liquid, leaving reaction products of surface material in the coating, e.g. conversion coatings, passivation of metals using aqueous solutions
- C23C22/60—Chemical surface treatment of metallic material by reaction of the surface with a reactive liquid, leaving reaction products of surface material in the coating, e.g. conversion coatings, passivation of metals using aqueous solutions using alkaline aqueous solutions with pH greater than 8
- C23C22/64—Treatment of refractory metals or alloys based thereon
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/70—Nanostructure
- Y10S977/755—Nanosheet or quantum barrier/well, i.e. layer structure having one dimension or thickness of 100 nm or less
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/24—Structurally defined web or sheet [e.g., overall dimension, etc.]
- Y10T428/24942—Structurally defined web or sheet [e.g., overall dimension, etc.] including components having same physical characteristic in differing degree
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/25—Web or sheet containing structurally defined element or component and including a second component containing structurally defined particles
- Y10T428/256—Heavy metal or aluminum or compound thereof
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/26—Web or sheet containing structurally defined element or component, the element or component having a specified physical dimension
- Y10T428/263—Coating layer not in excess of 5 mils thick or equivalent
- Y10T428/264—Up to 3 mils
- Y10T428/265—1 mil or less
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/31504—Composite [nonstructural laminate]
- Y10T428/31678—Of metal
Definitions
- the present invention relates to a material and to a method of producing a material which is suitable for use as an implant or for use as a bone substitute for repairing bone.
- Titanium and its alloys due to their high toughness and excellent biocompatibility, are widely used in medical implants such as joint prostheses, fracture fixation devices, and dental implants.
- Other materials commonly used in medical and dental implants include cobalt chrome, polished zirconium, oxinium (zirconium oxide) and stainless steel.
- titanium and these other materials demonstrate poor ability to bond to bone chemically, and thus osteolysis and subsequent loosening of implants comprising these materials are common.
- the performance of an orthopaedic implant can be influenced by the quality of the interface formed between the implant and bone or bone cement.
- the development of the implant-to-bone (or cement) interface relies on a number of factors including surface area, charge, topography, chemistry and contamination of the implant.
- the implant-to-bone interface is the surface of the implant which interfaces or lies adjacent the bone when implanted.
- Implant-to-bone interface topography to enhance implant-to-bone integration.
- These techniques include plasma spraying and electrochemical anodising of the implant-to-bone interface surface.
- Problems associated with plasma spraying and electrochemical anodising include, the formation of an implant-to-bone interface which has low fatigue strength, demonstrates poor adherence to the implant, and suffers from degradation, delamination or cracking during long term implantation.
- a commonly used technique for improving tissue ingrowth into orthopaedic implants is abrasive particle blasting of the implant surface, alternatively known as grit-blasting or sand blasting.
- This, cost efficient process imparts a micron scale surface structure by blasting abrasive particles on the implant surface.
- Such roughened surfaces have been shown to promote cell attachment and thus improved physical implant-to-bone bonding.
- the increased area of a roughened surface means that more cells can attach to the implant-to-bone interface which also improves implant-to-bone physical bonding.
- the implant having such a modified implant-to-bone interface demonstrates good osseointegrative properties even in poor quality bone.
- the technique of abrasive particle blasting can cause significant changes to surface topography by damaging the metal elements on the surface of the implant.
- the technique of abrasive particle blasting can also cause heterogeneity of the surface chemistry due to the presence of abrasive particles embedded in the surface of the implant.
- the presence of the abrasive particles contaminate the surface of the implant and adversely affect the quality of the implant-to-bone interface.
- the abrasive particles can detach from the surface of the implant, leading to increased wear on the bone, implant and implant site.
- a percentage of the embedded abrasive particles protrude from the surface of the implant causing localised micromotion, movement of the implant relative to the implant site, and disruption of tissue ingrowth in the surface of the implant.
- Up to 40% of the surface area of the grit blasted implant can become contaminated with abrasive particles which can lead to implant-to-bone interface problems, reduced bio-compatibility of the implant and inflammation of the area local to the implant.
- the implant-to-bone interface is the surface of the implant which interfaces or lies adjacent the bone when implanted. It is also an object of the present invention to provide an implant which has a bioactive, porous and nano-structured surface layer with improved osteoconductive and osteoinductive properties.
- a material suitable as an implant comprising a metal or metal alloy substrate and a primary layer formed on a surface of the substrate, said primary layer having a surface area greater than the surface area of the substrate.
- the surface of the primary layer of the implant interfaces the bone or bone cement.
- the primary layer or more specifically, the surface of the primary layer provides the implant-to-bone interface.
- the increased surface area of the primary layer means that a larger surface area is presented to surrounding cells/cement for increased cell/cement attachment and hence improved integration with the material and thus with the implant.
- a method of forming the material of the first aspect comprising the steps of providing a metal or metal alloy substrate and forming a primary layer on a surface of the substrate such that the surface area of the primary layer is greater than the surface area of the substrate covered by the primary layer.
- the substrate comprises a transition metal, a transition metal alloy or a transition metal oxide, for example, titanium, TiAlNb, or titanium oxide.
- a transition metal for example, titanium, TiAlNb, or titanium oxide.
- Titanium and its alloys due to their high toughness and excellent biocompatibility are ideally suited as orthopaedic implants.
- the substrate may comprise cobalt chrome, polished zirconium, oxinium (zirconium oxide), stainless steel, tantalum or any combination of these.
- the substrate according to the present invention may comprise any metal, or metal alloy, or metal oxide or combination of these but suitably it would comprise titanium.
- the step of forming the primary layer on the metal substrate comprises physically altering the surface of the substrate.
- Physically altering the surface of the substrate roughens the surface of the substrate thereby increasing its surface area.
- the primary or rough layer promotes cell attachment and thus physical bonding of the implant to bone or to the implant site.
- the roughened surface presented by the primary layer provides a surface area significantly larger than the surface area of the substrate covered by the primary layer.
- the step of physically altering the surface of the substrate to form the primary layer may comprise, for example, machining, sand blasting or grit blasting, or any combination of these.
- the physical altering step comprises grit blasting the surface of the substrate with abrasive particles such as alumina.
- the primary layer thus formed presents a roughened, uneven surface texture of peaks, troughs, pits and trenches which increases the surface area available for cell attachment.
- the step of physically altering the substrate may comprise, for example, a macro or micro physical surface-treatment in which a coating of metallic beads is adhered to the surface of the substrate.
- the beads form a 3D porous geometry on the surface of the substrate thereby providing a primary layer having a greater surface area than the surface of the substrate covered by the coating.
- the primary layer comprises a double or triple layer of beads sintered onto the surface of the substrate.
- the beads are titanium beads and have a mean diameter of 328 ⁇ m.
- the coating may contain a sponge or foam like network of metallic fibres and/or wires.
- the substrate itself can be porous or sponge like, negating the requirement to physically treat the surface of the substrate.
- the foam or sponge-like structure is composed of sintered beads having diameters of between 15 and 50 ⁇ m and pore diameters of several hundred microns to approximately 1 mm.
- the method of forming or completing the primary layer ideally includes chemically treating the physically formed primary layer.
- the step of chemically treating the physically formed primary layer comprises soaking the substrate in an alkaline solution at approximately 30-90° C.
- the titanium or titanium alloy reacts with the alkaline solution to form alkali titanates.
- the surface of the completed primary layer thus comprises alkali titanates.
- the surface of the completed primary layer also includes titanium oxide or titanium oxides.
- the temperature of the alkaline solution is between 50-70° C. and more preferably between 55-65° C.
- the substrate is soaked in an alkaline solution for between 1 and 24 hours.
- the soaking time is between 1 and 5 hours but is preferably between 1 and 3 hours. It has been found that soaking times above 5 hours but in particular above 24 hours also produce a primary layer having a thickness in the micron scale.
- the alkali titanate layer creates a surface to the primary layer which comprises a nanostructure of alkali titanates.
- a nanostructure or nano-textured surface generally means a surface which includes particles or elements of a size falling within the nanometer range.
- the nanostructure of alkali titanates resembles a strut-like morphology containing discrete elements, structurally resembling fibres or fibrils, of alkali titanate having a width of between 1 and 20 nanometers (nm).
- the fibrils are generally cylindrical in shape.
- the length of the fibrils range from 200-300 nm and the distance between fibrils ranges from 5 nm to 80 nm.
- the fibrils are generally overlaid or stacked one atop another forming the alkali titanate layer or surface.
- the thickness of the alkali titanate layer is in the range of 100-500 nanometers, more preferably 100-300 nanometers.
- the physical treatment step creates the primary layer having an increased surface area in preparation for the formation of the alkali titanate nanostructure.
- the nanostructure of the alkai titanate layer completes the primary layer and significantly increases the surface area of the primary layer and hence implant-to-bone interface surface area available for cell attachment and integration.
- the alkali titanate layer also masks the adverse affects caused by the presence of any abrasive particles present in the implant-to-bone interface of the implant.
- the primary layer has a surface area of between 1000 and 50000 times greater than the surface area of the substrate covered by the primary layer. More preferably, the primary layer has a surface area of between 20000 and 50000 times and ideally between 40000 and 50000 times greater than the surface area of the substrate covered by the primary layer.
- the alkaline solution comprises a hydroxide.
- the hydroxide is sodium hydroxide.
- Other hydroxides can be used with the present invention, e.g. lithium hydroxide or potassium hydroxide or any other suitable metal hydroxide.
- the alkali titanate nanostructure of the primary layer will be sodium titanate.
- Sodium titanate is an ionic compound that can be readily modified by ion-exchange chemistry into other compounds such as lithium titanate or strontium titanate to confer different physico-chemical or biocompatibility characteristics suitable for different applications.
- the concentration of the hydroxide solution is preferably between 2 and 8 molar, more preferably between 3 and 6 molar, and ideally 4 molar. Higher concentrations of hydroxide can lead to re-dissolution of the nanostructure.
- the primary layer formed is typically hydrophilic in nature. This is generally due to the chemical treatment step in completing the primary layer.
- the hydrophilic nature of a material is generally measured by the contact angle water forms on its surface. The smaller the contact angle the greater the hydrophilic nature of the material.
- the contact angle of the primary layer is less than 5°, more preferably is less than 3°.
- the primary layer has a low reflectance to visible light.
- the primary layer has a reflectance to visible light in the range of 1% to 20%. More preferably, the primary layer has a reflectance to visible light in the range of 5% to 15% and ideally in the range of 6% to 10%.
- the reflectance range gives the primary layer a black colour.
- the primary layer includes hydroxyapatite, for example calcium hydroxyapatite.
- hydroxyapatite for example calcium hydroxyapatite.
- the hydroxyapatite is incorporated in the primary layer by soaking the material in mixed buffer salts.
- the material may be used in both medical and dental implants for improved implant-to-bone integration. More specifically, the material may be used in bone replacement implants including, for example, knee joint, hip joint and shoulder joint prosthesis, femoral neck replacement, spine replacement and repair, neck bone replacement and repair, jaw bone repair, fixation and augmentation, transplanted bone fixation, and other limb prosthesis.
- bone replacement implants including, for example, knee joint, hip joint and shoulder joint prosthesis, femoral neck replacement, spine replacement and repair, neck bone replacement and repair, jaw bone repair, fixation and augmentation, transplanted bone fixation, and other limb prosthesis.
- FIG. 1 is a scanning electron micrograph (SEM) of a titanium alloy surface
- FIG. 2 is an SEM of the titanium alloy surface of FIG. 1 after grit blasting with alumina particles
- FIG. 3 is an SEM of a titanium alloy porous beaded surface
- FIG. 4 is an SEM of a titanium alloy sintered bead foam surface
- FIG. 5 a is an SEM of titanium alloy surface after grit blasting with alumina particles
- FIGS. 5 b -5 g are SEMs of samples of the titanium alloy surface of FIG. 5 a after soaking in a 2M (2 molar), 3M, 4M, 6M, 8M and 10M solution respectively of sodium hydroxide solution at 60° C. for 2 hours;
- FIG. 6 a -6 c are SEMs of an alumina grit blast titanium alloy surface, a titanium porous beaded surface, and a titanium sintered bead foam surface respectively, soaked in a 4M sodium hydroxide solution at 60° C. for 2 hours;
- FIGS. 7 and 8 are magnified views of the titanium alloy surfaces FIG. 6 b and FIG. 6 c respectively;
- FIG. 9 is an SEM of a Porous Beaded Titanium surface prior to forming the primary layer
- FIG. 10 is an SEM of the porous beaded titanium surface of FIG. 9 , the primary layer having been formed by soaking in a 4M sodium hydroxide solution at 60° C. for 2 hours in a sonicating water bath;
- FIG. 11 a is an SEM of the Porous Beaded Titanium surface of FIG. 9 soaked in a 2M solution of sodium hydroxide at 60° C. for 10 minutes;
- FIG. 11 b is a magnified SEM of the Porous Beaded Titanium surface of FIG. 11 a , more clearly showing the early formation of the nanostructured primary layer comprising nano-sized fibrils having a size in the region of 1-20 nanometers;
- FIG. 11 e is an SEM of the Porous Beaded Titanium surface of FIG. 11 a soaked in a 2 Molar solution of sodium hydroxide at 60° C. for a further 15 minutes clearly showing the development of the nanostructured primary layer;
- FIG. 11 d is an SEM of a different portion of the Porous Beaded Titanium surface of FIG. 11 a clearly showing the irregular nature of the formation of the primary layer;
- FIG. 12 is an SEM of a commercially pure titanium surface after grit blasting with alumina particles with subsequent soaking in a 4M solution of sodium hydroxide solution at 60° C. for 2 hours;
- FIGS. 13 a -13 c are SEMs of increasing magnification of areas of the surface of TiAlNb alloy after grit blasting with alumina particles but prior to soaking in sodium hydroxide, the SEM employing a 2 kv beam to analyse the upper structure of the primary layer created;
- FIGS. 14 a -14 c are SEMs of the same areas of the surface of the TiAlNb alloy of FIGS. 13 a -13 c after soaking in 4M sodium hydroxide solution at 60° C. for 2 hours, the SEM employing a 2 kv beam to analyse the upper structure of the completed primary layer;
- FIGS. 15 a and 15 b are SEMs of the same areas of the surface of the TiAlNb alloy of FIGS. 14 b and 14 c respectively, the SEM employing a 15 kv beam to analyse the substructure of the completed primary layer;
- FIG. 16 is a graph showing the percentage reflectance from the surface of the primary layer for different substrates.
- FIGS. 17 a and 17 b are pictorial views of samples of the material according to the present invention showing the primary layer prior to treatment with sodium hydroxide and post treatment with sodium hydroxide respectively.
- FIG. 18 shows grit blasted titanium coupons p-NPP data normalised to DNA (Pico Green) with error bars of standard deviation. This data is from Table 2.
- FIG. 19 shows porous beaded titanium coupons p-NPP data normalised to DNA (Pico Green) with error bars of standard deviation. This data is from Table 3.
- FIG. 20 shows polished titanium coupons p-NPP data normalised to DNA (Pico Green) with error bars of standard deviation. This data is from Table 4.
- Sample titanium alloy plates of various dimensions having surface areas ranging from approximately 40 mm 2 to 100 mm 2 were washed cleaned and dried to form sample substrates.
- the prepared or sample substrate surfaces are approximately smooth. This can be seen most clearly from FIG. 1 which is a view of the substrate surface taken by a ultra-high resolution scanning electron microscope.
- a FEI Nova 200 NanoSEM ultra-high resolution Scanning Electron Microscope with a stated resolution of 1.8 nm at 3 kV and 1 nm at 15 kV using immersion optics was used to characterise primary layers formed on the titanium alloy substrate.
- the views or micrographs of the primary layer show detail on the nanoscale. However, it will be appreciated that other suitable methods and equipment may also be used to explore the surface detail of the primary layer.
- FIGS. 2 and 5 a A surface of a prepared substrate sample was blasted with abrasive alumina particles otherwise known as alumina grit-blast.
- the process of alumina grit-blasting roughens the surface of the substrate creating or partially forming a primary layer which has a greater surface area than the surface area of the prepared substrate prior to grit-blasting. This can be seen most clearly in FIGS. 2 and 5 a .
- the primary layer was completed by soaking the substrate with the partially formed primary layer in a 4 molar solution of sodium hydroxide at 60° C. for two hours.
- FIG. 5 b is a view of the completed primary layer which clearly shows the development of strut-like formations, fibres or fibrils of sodium titanate having dimensions on the nanoscale. The diameter or width of these fibrils fall within the range of between 1 and 20 nanometers. Approximately 80% of the fibrils have been measured as having a diameter in the range of 5 to 12 nanometers. The length of the fibrils
- FIGS. 5 c to 5 g are views of the completed primary layer formed in each case.
- FIGS. 5 c to 5 g the best etching, texturing or nanostructure formed or greatest density of fibril formation was observed where the substrate was soaked in 4 molar solution of sodium hydroxide. The greater the density of fibril formation, the greater the surface area of the primary layer. Treatment with higher concentrations of sodium hydroxide was less effective and lead to re-dissolution of the nanostructure of the primary layer resulting in a smoother surface and thus a reduced surface area.
- FIGS. 6 a to 6 c are views of a primary layer formed according to the present invention wherein the starting substrate and thus the initial topography is different in each case.
- FIG. 6 a is a view of a primary layer which has been formed on a surface of a solid titanium alloy substrate which has been blasted with abrasive alumina particles and subsequently chemically treated by soaking in a 4 molar concentrated solution of sodium hydroxide at 60° C. for 2 hours.
- FIG. 6 b and FIG. 6 c are views of the primary layer which have been formed on a surface of a porous beaded titanium substrate and a titanium foam substrate respectively, which have been chemically treated in the same way as the solid titanium alloy substrate.
- FIG. 9 is an SEM of a portion of a surface of a porous beaded titanium alloy prior to completing the primary layer.
- FIGS. 11 a to 11 d illustrate the development of the primary layer over time when soaked in a 2 molar solution of sodium hydroxide at 60° C.
- FIGS. 13 a -13 c are SEMs of increasing magnification (200, 500 and 1200 times magnified respectively) of areas of the surface of TiAlNb alloy after grit blasting with alumina particles but prior to soaking in sodium hydroxide; the SEM employing a 2 kv beam to analyse the upper structure of the completed primary layer.
- FIGS. 14 a -14 c are SEMs of the same areas and at the same magnifications of the surface of the TiAlNb alloy of FIGS. 13 a -13 c respectively after soaking in 4 molar sodium hydroxide solution at 60° C. for 2 hours; the SEM employing a 2 kv beam to analyse the upper structure of the primary layer thus formed.
- FIGS. 14 a -14 c are SEMs of the same areas and at the same magnifications of the surface of the TiAlNb alloy of FIGS. 13 a -13 c respectively after soaking in 4 molar sodium hydroxide solution at 60° C.
- 15 a and 15 b are SEMs of same areas and at the same magnifications of the surface of the TiAlNb alloy of FIGS. 13 b and 13 c respectively; the SEM employing a 15 kv beam to analyse the substructure of the primary layer formed.
- the surfaces of the primary layers were analysed by scanning electron microscopy (SEM) before and after soaking the substrate in sodium hydroxide solution to analyse surface topography and alumina content throughout the primary layer.
- SEM scanning electron microscopy
- This technique can be carried out at different voltages which enables the surface and subsurface of the primary layer to be analysed; the greater the voltage the deeper the penetration of the beam.
- Titanium alloy has a higher average atomic number than alumina. The higher the average atomic number of the material being analysed using SEM, the greater will be the electron backscatter and thus the brighter will be the SEM image.
- FIG. 1 which shows a titanium alloy substrate prior to alumina grit blasting
- FIGS. 13 a to 13 c show the titanium alloy substrate post alumina grit blasting
- FIGS. 14 a to 14 c represent the primary layer of FIGS. 13 a to 13 c which have been completed by chemical treatment with sodium hydroxide as described above.
- 14 a to 14 c are brighter than the SEM images of the primary layer illustrated in FIGS. 13 a to 13 c because the sodium titanate layer formed masks the alumina particles present in the upper surface of the primary layer.
- Sodium titanate has an average atomic number higher than that of alumina and thus the SEM image of the completed primary layer will appear brighter than the primary layer created by alumina grit blasting and prior to treatment with sodium hydroxide.
- the higher voltage SEM images illustrate the composition of the subsurface of the primary layer which is clearly darker and thus higher in alumina content than the upper surface regions.
- Sample titanium materials, titanium alloy coupons, having different pre-treatments were compared for osteogenic activity on the surface after being chemically treated with an alkaline solution, compared to each other type and of pre-treatment and to not being chemically treated.
- the alkaline solution was a 4 molar solution of sodium hydroxide for 2 hours at 60° (as described here before).
- the pre-treatments of the titanium alloy coupons were polishing the surface, grit blasting and porous beading as known in the art.
- Human mesenchymal stem cells were resurrected and passaged in suitable medium and incubated overnight. After incubation the medium was replaced with an osteogenic medium containing R-Glycerophosphate and this was changed twice a week.
- Live/dead staining on the cells was performed on all surface types at all time points.
- the samples were subject to cell lysis and P-nitrophenol alkaline phosphatase p-NPP assay analysis to indicated osteogenic activity of the cells and thus, bone formation.
- Table 3 shows pre-treated porous beaded coupons with and without alkaline solution treatment.
- Table 4 shows polished coupons with and without alkaline solution treatment.
- the primary layer may include various bio-active materials including antimicrobials. It will also be appreciated that the primary layer may be further treated to impart anti-biofouling, cytogenic, catalytic, osteogenic or electrochemical properties to the implant.
- the substrate may comprise other metals or alloys instead of titanium, for example, nitinol or zirconium.
- the material formed maybe subjected to further physical treatment steps to improve or enhance the surface characteristics of the primary surface layer.
- the material on completion of the primary layer, can be rinsed in water or phosphate buffered-saline solution to remove the alkali. After drying the material, it can be heated to a target temperature of between 300-600° C. The target temperature can be reached by raising the temperature of the material by 5° C. per minute. The target temperature, once reached can be maintained for at least one hour.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Metallurgy (AREA)
- Mechanical Engineering (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Surgery (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
Abstract
Description
- The present invention relates to a material and to a method of producing a material which is suitable for use as an implant or for use as a bone substitute for repairing bone.
- Restoration of skeletal defects or wounds such as femoral neck fracture, spine fusion and lost teeth is a common procedure. For example, over 500,000 hip prosthesis implantations, 250,000 spine fusion surgeries, and 500,000 dental implant surgeries are performed annually in the United States alone.
- Titanium and its alloys, due to their high toughness and excellent biocompatibility, are widely used in medical implants such as joint prostheses, fracture fixation devices, and dental implants. Other materials commonly used in medical and dental implants, include cobalt chrome, polished zirconium, oxinium (zirconium oxide) and stainless steel. However, titanium and these other materials demonstrate poor ability to bond to bone chemically, and thus osteolysis and subsequent loosening of implants comprising these materials are common.
- The performance of an orthopaedic implant can be influenced by the quality of the interface formed between the implant and bone or bone cement. The development of the implant-to-bone (or cement) interface relies on a number of factors including surface area, charge, topography, chemistry and contamination of the implant. The implant-to-bone interface is the surface of the implant which interfaces or lies adjacent the bone when implanted.
- Various techniques are known to modify the implant-to-bone interface topography to enhance implant-to-bone integration. These techniques include plasma spraying and electrochemical anodising of the implant-to-bone interface surface. Problems associated with plasma spraying and electrochemical anodising include, the formation of an implant-to-bone interface which has low fatigue strength, demonstrates poor adherence to the implant, and suffers from degradation, delamination or cracking during long term implantation.
- A commonly used technique for improving tissue ingrowth into orthopaedic implants is abrasive particle blasting of the implant surface, alternatively known as grit-blasting or sand blasting. This, cost efficient process, imparts a micron scale surface structure by blasting abrasive particles on the implant surface. Such roughened surfaces have been shown to promote cell attachment and thus improved physical implant-to-bone bonding. Furthermore, the increased area of a roughened surface means that more cells can attach to the implant-to-bone interface which also improves implant-to-bone physical bonding. The implant having such a modified implant-to-bone interface demonstrates good osseointegrative properties even in poor quality bone.
- However the technique of abrasive particle blasting can cause significant changes to surface topography by damaging the metal elements on the surface of the implant. The technique of abrasive particle blasting can also cause heterogeneity of the surface chemistry due to the presence of abrasive particles embedded in the surface of the implant. The presence of the abrasive particles contaminate the surface of the implant and adversely affect the quality of the implant-to-bone interface. Furthermore, the abrasive particles can detach from the surface of the implant, leading to increased wear on the bone, implant and implant site.
- Additionally, a percentage of the embedded abrasive particles protrude from the surface of the implant causing localised micromotion, movement of the implant relative to the implant site, and disruption of tissue ingrowth in the surface of the implant. Up to 40% of the surface area of the grit blasted implant can become contaminated with abrasive particles which can lead to implant-to-bone interface problems, reduced bio-compatibility of the implant and inflammation of the area local to the implant.
- It is the object of the present invention to provide an implant which has an enlarged implant-to-bone interface layer with reduced or no contamination caused by surface embedded abrasive particles. The implant-to-bone interface is the surface of the implant which interfaces or lies adjacent the bone when implanted. It is also an object of the present invention to provide an implant which has a bioactive, porous and nano-structured surface layer with improved osteoconductive and osteoinductive properties.
- Therefore, according to a first aspect of the invention, there is provided a material suitable as an implant comprising a metal or metal alloy substrate and a primary layer formed on a surface of the substrate, said primary layer having a surface area greater than the surface area of the substrate. Surprisingly it has been found that the primary layer according to the present invention, having a surface area greater than the surface area of the substrate, encourages (to a greater extent) bone to be formed on the surface. Thus increasing bone formation and giving a secure hold on the implant, giving a greater implant success rate both in terms of speed to recover from the implant operation and overall success of the implant being secured in place.
- In use, the surface of the primary layer of the implant interfaces the bone or bone cement. Thus, the primary layer, or more specifically, the surface of the primary layer provides the implant-to-bone interface. The increased surface area of the primary layer means that a larger surface area is presented to surrounding cells/cement for increased cell/cement attachment and hence improved integration with the material and thus with the implant.
- According to a second aspect of the invention, there is provided a method of forming the material of the first aspect, comprising the steps of providing a metal or metal alloy substrate and forming a primary layer on a surface of the substrate such that the surface area of the primary layer is greater than the surface area of the substrate covered by the primary layer.
- Preferably, the substrate comprises a transition metal, a transition metal alloy or a transition metal oxide, for example, titanium, TiAlNb, or titanium oxide. Titanium and its alloys, due to their high toughness and excellent biocompatibility are ideally suited as orthopaedic implants. Optionally, the substrate may comprise cobalt chrome, polished zirconium, oxinium (zirconium oxide), stainless steel, tantalum or any combination of these. The substrate according to the present invention may comprise any metal, or metal alloy, or metal oxide or combination of these but suitably it would comprise titanium.
- Preferably, the step of forming the primary layer on the metal substrate comprises physically altering the surface of the substrate. Physically altering the surface of the substrate roughens the surface of the substrate thereby increasing its surface area. The primary or rough layer promotes cell attachment and thus physical bonding of the implant to bone or to the implant site. The roughened surface presented by the primary layer provides a surface area significantly larger than the surface area of the substrate covered by the primary layer.
- The step of physically altering the surface of the substrate to form the primary layer may comprise, for example, machining, sand blasting or grit blasting, or any combination of these. Preferably, the physical altering step comprises grit blasting the surface of the substrate with abrasive particles such as alumina. The primary layer thus formed presents a roughened, uneven surface texture of peaks, troughs, pits and trenches which increases the surface area available for cell attachment.
- Alternatively, the step of physically altering the substrate may comprise, for example, a macro or micro physical surface-treatment in which a coating of metallic beads is adhered to the surface of the substrate. The beads form a 3D porous geometry on the surface of the substrate thereby providing a primary layer having a greater surface area than the surface of the substrate covered by the coating. Preferably, the primary layer comprises a double or triple layer of beads sintered onto the surface of the substrate. Preferably, the beads are titanium beads and have a mean diameter of 328 μm.
- Alternatively, or in addition, the coating may contain a sponge or foam like network of metallic fibres and/or wires. Alternatively, the substrate itself can be porous or sponge like, negating the requirement to physically treat the surface of the substrate. Preferably, the foam or sponge-like structure is composed of sintered beads having diameters of between 15 and 50 μm and pore diameters of several hundred microns to approximately 1 mm.
- In addition, and subsequent to the physically formed primary layer, the method of forming or completing the primary layer ideally includes chemically treating the physically formed primary layer. The step of chemically treating the physically formed primary layer comprises soaking the substrate in an alkaline solution at approximately 30-90° C. The titanium or titanium alloy reacts with the alkaline solution to form alkali titanates. The surface of the completed primary layer thus comprises alkali titanates. Typically, the surface of the completed primary layer also includes titanium oxide or titanium oxides.
- Preferably, the temperature of the alkaline solution is between 50-70° C. and more preferably between 55-65° C.
- It has been found that to heat the substrate or alkaline solution to a higher temperature can compromise the integrity of the primary layer so formed. For example, where the substrate or alkaline solution is heated to or above 150° C., a primary layer having a deposit of alkali titanates of a thickness in the micron scale will form. The thicker the alkali titanate deposit or layer, the greater will be the risk of delamination or cracking of the alkali titanate layer. Thus the alkali titanate layer, which will in effect form the implant-to-bone interface, bonding the implant to the bone, may be weak and ultimately fail causing separation of the implant from the bone.
- Preferably, the substrate is soaked in an alkaline solution for between 1 and 24 hours. Typically, the soaking time is between 1 and 5 hours but is preferably between 1 and 3 hours. It has been found that soaking times above 5 hours but in particular above 24 hours also produce a primary layer having a thickness in the micron scale.
- The alkali titanate layer creates a surface to the primary layer which comprises a nanostructure of alkali titanates. A nanostructure or nano-textured surface generally means a surface which includes particles or elements of a size falling within the nanometer range. The nanostructure of alkali titanates resembles a strut-like morphology containing discrete elements, structurally resembling fibres or fibrils, of alkali titanate having a width of between 1 and 20 nanometers (nm). The fibrils are generally cylindrical in shape.
- Typically, the length of the fibrils range from 200-300 nm and the distance between fibrils ranges from 5 nm to 80 nm. The fibrils are generally overlaid or stacked one atop another forming the alkali titanate layer or surface. Preferably, the thickness of the alkali titanate layer is in the range of 100-500 nanometers, more preferably 100-300 nanometers.
- The physical treatment step creates the primary layer having an increased surface area in preparation for the formation of the alkali titanate nanostructure. The nanostructure of the alkai titanate layer completes the primary layer and significantly increases the surface area of the primary layer and hence implant-to-bone interface surface area available for cell attachment and integration. The alkali titanate layer also masks the adverse affects caused by the presence of any abrasive particles present in the implant-to-bone interface of the implant.
- Preferably, the primary layer has a surface area of between 1000 and 50000 times greater than the surface area of the substrate covered by the primary layer. More preferably, the primary layer has a surface area of between 20000 and 50000 times and ideally between 40000 and 50000 times greater than the surface area of the substrate covered by the primary layer.
- Typically, the alkaline solution comprises a hydroxide. Preferably, the hydroxide is sodium hydroxide. Other hydroxides can be used with the present invention, e.g. lithium hydroxide or potassium hydroxide or any other suitable metal hydroxide. In this case, the alkali titanate nanostructure of the primary layer will be sodium titanate. Sodium titanate is an ionic compound that can be readily modified by ion-exchange chemistry into other compounds such as lithium titanate or strontium titanate to confer different physico-chemical or biocompatibility characteristics suitable for different applications. The concentration of the hydroxide solution is preferably between 2 and 8 molar, more preferably between 3 and 6 molar, and ideally 4 molar. Higher concentrations of hydroxide can lead to re-dissolution of the nanostructure.
- The primary layer formed is typically hydrophilic in nature. This is generally due to the chemical treatment step in completing the primary layer. The hydrophilic nature of a material is generally measured by the contact angle water forms on its surface. The smaller the contact angle the greater the hydrophilic nature of the material. Preferably, the contact angle of the primary layer is less than 5°, more preferably is less than 3°.
- Preferably, the primary layer has a low reflectance to visible light. Typically, the primary layer has a reflectance to visible light in the range of 1% to 20%. More preferably, the primary layer has a reflectance to visible light in the range of 5% to 15% and ideally in the range of 6% to 10%. The reflectance range gives the primary layer a black colour.
- Preferably, the primary layer includes hydroxyapatite, for example calcium hydroxyapatite. Typically, the hydroxyapatite is incorporated in the primary layer by soaking the material in mixed buffer salts.
- The material may be used in both medical and dental implants for improved implant-to-bone integration. More specifically, the material may be used in bone replacement implants including, for example, knee joint, hip joint and shoulder joint prosthesis, femoral neck replacement, spine replacement and repair, neck bone replacement and repair, jaw bone repair, fixation and augmentation, transplanted bone fixation, and other limb prosthesis.
- Embodiments of the invention will now be described by way of example only and with reference to the accompanying drawings, in which:—
-
FIG. 1 is a scanning electron micrograph (SEM) of a titanium alloy surface; -
FIG. 2 is an SEM of the titanium alloy surface ofFIG. 1 after grit blasting with alumina particles; -
FIG. 3 is an SEM of a titanium alloy porous beaded surface; -
FIG. 4 is an SEM of a titanium alloy sintered bead foam surface; -
FIG. 5a is an SEM of titanium alloy surface after grit blasting with alumina particles; -
FIGS. 5b-5g are SEMs of samples of the titanium alloy surface ofFIG. 5a after soaking in a 2M (2 molar), 3M, 4M, 6M, 8M and 10M solution respectively of sodium hydroxide solution at 60° C. for 2 hours; -
FIG. 6a-6c are SEMs of an alumina grit blast titanium alloy surface, a titanium porous beaded surface, and a titanium sintered bead foam surface respectively, soaked in a 4M sodium hydroxide solution at 60° C. for 2 hours; -
FIGS. 7 and 8 are magnified views of the titanium alloy surfacesFIG. 6b andFIG. 6c respectively; -
FIG. 9 is an SEM of a Porous Beaded Titanium surface prior to forming the primary layer; -
FIG. 10 is an SEM of the porous beaded titanium surface ofFIG. 9 , the primary layer having been formed by soaking in a 4M sodium hydroxide solution at 60° C. for 2 hours in a sonicating water bath; -
FIG. 11a is an SEM of the Porous Beaded Titanium surface ofFIG. 9 soaked in a 2M solution of sodium hydroxide at 60° C. for 10 minutes; -
FIG. 11b is a magnified SEM of the Porous Beaded Titanium surface ofFIG. 11a , more clearly showing the early formation of the nanostructured primary layer comprising nano-sized fibrils having a size in the region of 1-20 nanometers; -
FIG. 11e is an SEM of the Porous Beaded Titanium surface ofFIG. 11a soaked in a 2 Molar solution of sodium hydroxide at 60° C. for a further 15 minutes clearly showing the development of the nanostructured primary layer; -
FIG. 11d is an SEM of a different portion of the Porous Beaded Titanium surface ofFIG. 11a clearly showing the irregular nature of the formation of the primary layer; -
FIG. 12 is an SEM of a commercially pure titanium surface after grit blasting with alumina particles with subsequent soaking in a 4M solution of sodium hydroxide solution at 60° C. for 2 hours; -
FIGS. 13a-13c are SEMs of increasing magnification of areas of the surface of TiAlNb alloy after grit blasting with alumina particles but prior to soaking in sodium hydroxide, the SEM employing a 2 kv beam to analyse the upper structure of the primary layer created; -
FIGS. 14a-14c are SEMs of the same areas of the surface of the TiAlNb alloy ofFIGS. 13a-13c after soaking in 4M sodium hydroxide solution at 60° C. for 2 hours, the SEM employing a 2 kv beam to analyse the upper structure of the completed primary layer; -
FIGS. 15a and 15b are SEMs of the same areas of the surface of the TiAlNb alloy ofFIGS. 14b and 14c respectively, the SEM employing a 15 kv beam to analyse the substructure of the completed primary layer; -
FIG. 16 is a graph showing the percentage reflectance from the surface of the primary layer for different substrates; and -
FIGS. 17a and 17b are pictorial views of samples of the material according to the present invention showing the primary layer prior to treatment with sodium hydroxide and post treatment with sodium hydroxide respectively. -
FIG. 18 shows grit blasted titanium coupons p-NPP data normalised to DNA (Pico Green) with error bars of standard deviation. This data is from Table 2. -
FIG. 19 shows porous beaded titanium coupons p-NPP data normalised to DNA (Pico Green) with error bars of standard deviation. This data is from Table 3. -
FIG. 20 shows polished titanium coupons p-NPP data normalised to DNA (Pico Green) with error bars of standard deviation. This data is from Table 4. - Sample titanium alloy plates of various dimensions having surface areas ranging from approximately 40 mm2 to 100 mm2 were washed cleaned and dried to form sample substrates. The prepared or sample substrate surfaces are approximately smooth. This can be seen most clearly from
FIG. 1 which is a view of the substrate surface taken by a ultra-high resolution scanning electron microscope. - A FEI Nova 200 NanoSEM ultra-high resolution Scanning Electron Microscope with a stated resolution of 1.8 nm at 3 kV and 1 nm at 15 kV using immersion optics was used to characterise primary layers formed on the titanium alloy substrate. The views or micrographs of the primary layer show detail on the nanoscale. However, it will be appreciated that other suitable methods and equipment may also be used to explore the surface detail of the primary layer.
- A surface of a prepared substrate sample was blasted with abrasive alumina particles otherwise known as alumina grit-blast. The process of alumina grit-blasting roughens the surface of the substrate creating or partially forming a primary layer which has a greater surface area than the surface area of the prepared substrate prior to grit-blasting. This can be seen most clearly in
FIGS. 2 and 5 a. The primary layer was completed by soaking the substrate with the partially formed primary layer in a 4 molar solution of sodium hydroxide at 60° C. for two hours.FIG. 5b is a view of the completed primary layer which clearly shows the development of strut-like formations, fibres or fibrils of sodium titanate having dimensions on the nanoscale. The diameter or width of these fibrils fall within the range of between 1 and 20 nanometers. Approximately 80% of the fibrils have been measured as having a diameter in the range of 5 to 12 nanometers. The length of the fibrils are between 200 and 300 nanometers. - Five further samples of the prepared substrate were alumina grit blasted and soaked in sodium hydroxide solutions of
concentration 3 molar, 4 molar, 6 molar, 8 molar and 10 molar respectively at 60° C. for two hours andFIGS. 5c to 5g are views of the completed primary layer formed in each case. As can be seen fromFIGS. 5c to 5g , the best etching, texturing or nanostructure formed or greatest density of fibril formation was observed where the substrate was soaked in 4 molar solution of sodium hydroxide. The greater the density of fibril formation, the greater the surface area of the primary layer. Treatment with higher concentrations of sodium hydroxide was less effective and lead to re-dissolution of the nanostructure of the primary layer resulting in a smoother surface and thus a reduced surface area. -
FIGS. 6a to 6c are views of a primary layer formed according to the present invention wherein the starting substrate and thus the initial topography is different in each case.FIG. 6a is a view of a primary layer which has been formed on a surface of a solid titanium alloy substrate which has been blasted with abrasive alumina particles and subsequently chemically treated by soaking in a 4 molar concentrated solution of sodium hydroxide at 60° C. for 2 hours.FIG. 6b andFIG. 6c are views of the primary layer which have been formed on a surface of a porous beaded titanium substrate and a titanium foam substrate respectively, which have been chemically treated in the same way as the solid titanium alloy substrate. - The porous beaded titanium substrate and titanium foam substrate were not subjected to any physical treatment such as in the case of the solid titanium alloy substrate. It was found that the greater the surface area of the starting substrate, the greater the surface area of the primary layer formed. As can be quite clearly seen from
FIGS. 6a to 6c the fibrils formed in the case of the titanium foam substrate, which had the greatest starting substrate surface area, were the most fine, and thus fibril formation density was greatest presenting the highest primary layer surface area.FIG. 9 is an SEM of a portion of a surface of a porous beaded titanium alloy prior to completing the primary layer.FIGS. 11a to 11d illustrate the development of the primary layer over time when soaked in a 2 molar solution of sodium hydroxide at 60° C. -
FIGS. 13a-13c are SEMs of increasing magnification (200, 500 and 1200 times magnified respectively) of areas of the surface of TiAlNb alloy after grit blasting with alumina particles but prior to soaking in sodium hydroxide; the SEM employing a 2 kv beam to analyse the upper structure of the completed primary layer.FIGS. 14a-14c are SEMs of the same areas and at the same magnifications of the surface of the TiAlNb alloy ofFIGS. 13a-13c respectively after soaking in 4 molar sodium hydroxide solution at 60° C. for 2 hours; the SEM employing a 2 kv beam to analyse the upper structure of the primary layer thus formed.FIGS. 15a and 15b are SEMs of same areas and at the same magnifications of the surface of the TiAlNb alloy ofFIGS. 13b and 13c respectively; the SEM employing a 15 kv beam to analyse the substructure of the primary layer formed. - The surfaces of the primary layers were analysed by scanning electron microscopy (SEM) before and after soaking the substrate in sodium hydroxide solution to analyse surface topography and alumina content throughout the primary layer. This technique can be carried out at different voltages which enables the surface and subsurface of the primary layer to be analysed; the greater the voltage the deeper the penetration of the beam. Titanium alloy has a higher average atomic number than alumina. The higher the average atomic number of the material being analysed using SEM, the greater will be the electron backscatter and thus the brighter will be the SEM image.
- Alumina has an average atomic number less than titanium alloy and thus an SEM image of titanium alloy with alumina present is darker than titanium alloy without alumina. It is quite clear when comparing
FIG. 1 , which shows a titanium alloy substrate prior to alumina grit blasting, withFIGS. 13a to 13c , for example, which show the titanium alloy substrate post alumina grit blasting, that quite a substantial amount of alumina becomes embedded in the surface of the substrate forming the primary layer.FIGS. 14a to 14c represent the primary layer ofFIGS. 13a to 13c which have been completed by chemical treatment with sodium hydroxide as described above. As can be seen, the SEM images of the primary layer illustrated inFIGS. 14a to 14c are brighter than the SEM images of the primary layer illustrated inFIGS. 13a to 13c because the sodium titanate layer formed masks the alumina particles present in the upper surface of the primary layer. Sodium titanate has an average atomic number higher than that of alumina and thus the SEM image of the completed primary layer will appear brighter than the primary layer created by alumina grit blasting and prior to treatment with sodium hydroxide. - The higher voltage SEM images illustrate the composition of the subsurface of the primary layer which is clearly darker and thus higher in alumina content than the upper surface regions. However, it is only critical to mask the alumina particles in the upper surface of the primary layer which forms the implant-to-bone interface and thus is in direct contact with the bone, as contamination of the subsurface of the primary layer with abrasive particles has little affect on the bond formed between the bone and implant.
- Analysis of the reflectance of various substrates prior to and after treatment with 4 molar sodium hydroxide was also undertaken. As can be seen quite clearly from table I below, the greater the surface area of the primary layer, the less visible light is reflected. The titanium foam substrate which produced the primary layer having the greatest surface area reflected only between 5 and 10% of the visible light. All the primary layers completed were black in colour when viewed by the naked eye.
-
TABLE 1 4M NaOH 4M NaOH Control Control treated treated 4M NaOH Wavelength Grit-Blast Porous Control Grit-Blast Porous treated (nm) Ti6Al4V Beaded Ti Foam Ti Ti6Al4V Beaded Ti Foam Ti 400 22.83 17.99 17.61 12.71 4.78 5.56 410 23.23 18.32 17.86 12.61 4.94 5.71 420 23.6 18.58 18.05 12.53 5.06 5.82 430 23.95 18.75 18.19 12.47 5.12 5.88 440 24.26 18.92 18.3 12.47 5.18 5.96 450 24.55 19.17 18.44 12.54 5.31 6.1 460 24.82 19.42 18.6 12.67 5.45 6.25 470 25.11 19.6 18.8 12.88 5.59 6.39 480 25.39 19.79 19.03 13.14 5.72 6.53 490 25.64 19.99 19.31 13.41 5.84 6.63 500 25.92 20.28 19.61 13.74 5.98 6.76 510 26.3 20.75 19.92 14.18 6.2 7 520 26.67 21.19 20.21 14.63 6.4 7.23 530 26.89 21.4 20.42 14.99 6.51 7.37 540 27.07 21.54 20.61 15.33 6.6 7.49 550 27.76 21.72 20.8 15.7 6.7 7.61 560 27.44 21.89 20.97 16.06 6.8 7.74 570 27.6 22.02 21.09 16.41 6.91 7.88 580 27.74 22.15 21.19 16.72 7 8.01 590 27.87 22.32 21.27 16.95 7.02 8.1 600 27.99 22.51 21.35 17.15 7.04 8.19 610 28.12 22.68 21.48 17.36 7.15 8.31 620 28.28 22.85 21.67 17.6 7.3 8.46 630 28.52 23.06 21.95 17.95 7.54 8.63 640 28.78 23.27 22.23 18.29 7.74 8.8 650 28.9 23.4 22.34 18.42 7.73 8.92 660 28.96 23.51 22.38 18.45 7.62 9 670 29.04 23.65 22.41 18.46 7.55 9.06 680 29.14 23.79 22.46 18.47 7.52 9.11 690 29.31 23.88 22.59 18.48 7.55 9.18 700 29.52 23.94 22.78 18.49 7.63 9.27 - Sample titanium materials, titanium alloy coupons, having different pre-treatments (grit blasted, polished, porous beaded) were compared for osteogenic activity on the surface after being chemically treated with an alkaline solution, compared to each other type and of pre-treatment and to not being chemically treated.
- The alkaline solution was a 4 molar solution of sodium hydroxide for 2 hours at 60° (as described here before).
- The pre-treatments of the titanium alloy coupons were polishing the surface, grit blasting and porous beading as known in the art.
- After the chemical treatment the titanium alloy coupons were inserted into individual silicone tubes so that any fluid placed on to the coupon remained on the test surface. Coupons were then sterilised.
- Human mesenchymal stem cells were resurrected and passaged in suitable medium and incubated overnight. After incubation the medium was replaced with an osteogenic medium containing R-Glycerophosphate and this was changed twice a week.
- Live/dead staining on the cells was performed on all surface types at all time points.
- The samples were subject to cell lysis and P-nitrophenol alkaline phosphatase p-NPP assay analysis to indicated osteogenic activity of the cells and thus, bone formation.
- The results are as shown in Table 2 for grit blasted pre-treated coupons alkaline solution treated compared to not being subject to alkaline solution.
-
TABLE 2 GB GB GB GB Non- GB Non- GB Non- GB Non- GB treated Alkali treated Alkali treated Alkali treated Alkali Grit (Day (Day (Day (Day (Day (Day (Day (Day blasted 3) 3) 7) 7) 14) 14) 21) 21) p-NPP Rep 1 25.493 38.760 79.569 155.813 165.721 211.735 149.917 226.772 Rep 2 21.630 37.081 63.447 142.378 184.362 263.529 228.443 380.482 Rep 319.783 36.745 95.859 129.446 235.583 306.969 243.480 327.018 Pico Rep 1 6.702 5.965 5.227 7.439 11.863 7.439 10.388 9.651 Green Rep 2 6.702 6.702 6.702 5.227 10.388 5.965 8.176 8.176 Rep 36.702 7.439 6.702 5.965 9.651 7.439 10.388 8.176 Normal- Rep 1 3.804 6.498 15.222 20.945 13.970 28.463 14.432 23.498 isation Rep 2 3.228 5.533 9.467 27.237 17.748 44.183 27.940 46.535 Rep 32.952 4.939 14.304 21.703 24.411 41.265 23.439 39.996 Mean 3.328 5.657 12.998 23.295 18.709 37.970 21.937 36.676 Standard 0.435 0.787 3.092 3.435 5.286 8.362 6.878 11.872 deviation - Table 3 shows pre-treated porous beaded coupons with and without alkaline solution treatment.
-
TABLE 3 Porous Porous Porous Porous Non- Porous Alkali + Non- Porous Alkali + treated Alkali heat treated Alkali Heat Porous (Day (Day (Day (Day (Day (Day beaded 3) 3) 3) 7) 7) 7) p-NPP Rep 1 74.363 125.584 150.271 76.404 295.273 198.369 Rep 2 75.874 161.187 187.553 153.259 322.005 250.163 Rep 3 94.851 151.278 174.622 139.893 231.784 265.200 Pico Rep 1 14.074 5.965 8.914 10.388 8.914 6.702 Green Rep 2 8.914 8.176 8.914 11.125 9.651 6.702 Rep 3 8.176 8.176 8.176 9.651 7.439 6.702 Normal- Rep 1 5.284 21.055 16.859 7.355 33.126 29.600 isation Rep 2 8.512 19.714 21.041 13.776 33.366 37.328 Rep 3 11.601 18.502 21.357 14.495 31.158 39.572 Mean 8.466 19.757 19.752 11.875 32.550 35.500 Standard 3.159 1.277 2.511 3.931 1.212 5.231 deviation Porous Porous Porous Porous Non- Porous Alkali + Non- Porous Alkali + treated Alkali Heat treated Alkali Heat Porous (Day (Day (Day (Day (Day (Day beaded 14) 14) 14) 21) 21) 21) p-NPP Rep 1 612.718 1137.336 734.683 636.108 744.708 945.199 Rep 2 617.730 1132.324 709.622 843.282 968.589 1035.420 Rep 3 729.671 1052.127 846.624 764.757 1100.579 1017.041 Pico Rep 1 11.125 8.176 8.176 10.388 6.702 8.914 Green Rep 2 10.388 8.914 8.176 11.125 8.914 9.651 Rep 3 11.125 8.176 9.651 10.388 8.176 9.651 Normal- Rep 1 55.074 139.102 89.855 61.235 111.121 106.041 isation Rep 2 59.466 127.034 86.790 75.799 108.665 107.289 Rep 3 65.587 128.681 87.726 73.619 134.606 105.384 Mean 60.042 131.606 88.124 70.218 118.131 106.238 Standard 5.280 6.544 1.571 7.855 14.321 0.967 deviation - Table 4 shows polished coupons with and without alkaline solution treatment.
-
TABLE 4 Polished Polished Polished Polished Non- Polished Alkali + Non- Polished Alkali + treated Alkali heat treated Alkali heat (Day (Day (Day (Day (Day (Day Polished 3) 3) 3) 7) 7) 7) p-NPP Rep 1 20.287 37.920 38.088 136.668 186.209 87.630 Rep 2 24.149 34.729 31.203 94.683 152.958 118.866 Rep 3 20.119 36.913 31.203 67.477 148.927 132.133 Pico Rep 1 8.914 5.227 6.702 5.965 5.965 5.227 Green Rep 2 6.702 5.227 9.651 7.439 5.227 5.227 Rep 3 12.600 4.490 5.965 22.921 5.227 5.227 Normal- Rep 1 2.276 7.254 5.683 22.913 31.220 16.764 isation Rep 2 3.603 6.644 3.233 12.728 29.261 22.740 Rep 3 1.597 8.221 5.231 2.944 28.490 25.278 Mean 2.492 7.373 4.716 17.821 29.657 21.594 Standard 1.021 0.795 1.304 7.202 1.407 4.371 deviation Polished Polished Polished Polished Non- Polished Alkali + Non- Polished Alkali + treated Alkali Heat treated Alkali Heat (Day (Day (Day (Day (Day (Day Polished 14) 14) 14) 21) 21) 21) p-NPP Rep 1 206.723 527.509 158.271 288.590 −15.488 −20.500 Rep 2 265.200 470.703 357.091 352.079 908.442 484.069 Rep 3 196.699 554.241 731.342 7.903 527.509 388.836 Pico Rep 1 5.965 8.176 5.965 8.914 −0.671 0.067 Green Rep 2 6.702 5.227 5.227 8.176 8.176 9.651 Rep 3 7.439 5.965 7.439 0.067 7.439 6.702 Normal- Rep 1 34.659 64.517 26.535 32.377 23.091 −308.186 isation Rep 2 39.572 90.048 68.313 43.061 111.107 50.159 Rep 3 26.441 92.923 98.311 118.804 70.911 58.020 Mean 33.557 82.496 64.387 37.719 91.009 54.089 Standard 6.634 15.636 36.049 7.555 28.423 5.559 deviation - The results show that there is more Osteogenic activity where the coupons have been chemically treated e.g. with an alkaline solution compared to not being chemically treated.
- It will be appreciated that the primary layer may include various bio-active materials including antimicrobials. It will also be appreciated that the primary layer may be further treated to impart anti-biofouling, cytogenic, catalytic, osteogenic or electrochemical properties to the implant.
- It will be further appreciated that the substrate may comprise other metals or alloys instead of titanium, for example, nitinol or zirconium.
- It is envisaged that the material formed maybe subjected to further physical treatment steps to improve or enhance the surface characteristics of the primary surface layer. For example, on completion of the primary layer, the material can be rinsed in water or phosphate buffered-saline solution to remove the alkali. After drying the material, it can be heated to a target temperature of between 300-600° C. The target temperature can be reached by raising the temperature of the material by 5° C. per minute. The target temperature, once reached can be maintained for at least one hour.
- It will be appreciated that the invention is not limited to the embodiments hereinbefore described but may be varied in construction and detail within the scope of the appended claims.
Claims (20)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15/680,757 US20180014936A1 (en) | 2007-08-20 | 2017-08-18 | Bioactive material |
Applications Claiming Priority (12)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0716220A GB0716220D0 (en) | 2007-08-20 | 2007-08-20 | Bioactive material and method of making bioactive material |
| GB0716220.9 | 2007-08-20 | ||
| GB0717317A GB0717317D0 (en) | 2007-09-06 | 2007-09-06 | Bioactive material and method of making bioactive material |
| GB0717317.2 | 2007-09-06 | ||
| GB0801840A GB0801840D0 (en) | 2008-02-01 | 2008-02-01 | Bioactive material and method of making bioactive material |
| GB0801840.0 | 2008-02-01 | ||
| GB0811268A GB0811268D0 (en) | 2008-06-19 | 2008-06-19 | Bioactive material |
| GB0811268.2 | 2008-06-19 | ||
| PCT/GB2008/002814 WO2009024778A2 (en) | 2007-08-20 | 2008-08-19 | Bioactive material |
| US67423610A | 2010-11-12 | 2010-11-12 | |
| US14/595,837 US20150165089A1 (en) | 2007-08-20 | 2015-01-13 | Bioactive material |
| US15/680,757 US20180014936A1 (en) | 2007-08-20 | 2017-08-18 | Bioactive material |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US14/595,837 Continuation US20150165089A1 (en) | 2007-08-20 | 2015-01-13 | Bioactive material |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20180014936A1 true US20180014936A1 (en) | 2018-01-18 |
Family
ID=40280858
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US12/674,236 Active 2030-02-08 US8980425B2 (en) | 2007-08-20 | 2008-08-19 | Bioactive material |
| US14/595,837 Abandoned US20150165089A1 (en) | 2007-08-20 | 2015-01-13 | Bioactive material |
| US15/680,757 Abandoned US20180014936A1 (en) | 2007-08-20 | 2017-08-18 | Bioactive material |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US12/674,236 Active 2030-02-08 US8980425B2 (en) | 2007-08-20 | 2008-08-19 | Bioactive material |
| US14/595,837 Abandoned US20150165089A1 (en) | 2007-08-20 | 2015-01-13 | Bioactive material |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US8980425B2 (en) |
| EP (1) | EP2200669B1 (en) |
| JP (2) | JP6165408B2 (en) |
| AT (1) | ATE538816T1 (en) |
| AU (1) | AU2008290373B2 (en) |
| CA (1) | CA2696954C (en) |
| ES (1) | ES2379304T3 (en) |
| WO (1) | WO2009024778A2 (en) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6520964B2 (en) | 2000-05-01 | 2003-02-18 | Std Manufacturing, Inc. | System and method for joint resurface repair |
| US6610067B2 (en) | 2000-05-01 | 2003-08-26 | Arthrosurface, Incorporated | System and method for joint resurface repair |
| US7896885B2 (en) | 2002-12-03 | 2011-03-01 | Arthrosurface Inc. | Retrograde delivery of resurfacing devices |
| US7678151B2 (en) * | 2000-05-01 | 2010-03-16 | Ek Steven W | System and method for joint resurface repair |
| US7896883B2 (en) | 2000-05-01 | 2011-03-01 | Arthrosurface, Inc. | Bone resurfacing system and method |
| US8177841B2 (en) | 2000-05-01 | 2012-05-15 | Arthrosurface Inc. | System and method for joint resurface repair |
| US7163541B2 (en) * | 2002-12-03 | 2007-01-16 | Arthrosurface Incorporated | Tibial resurfacing system |
| US7901408B2 (en) | 2002-12-03 | 2011-03-08 | Arthrosurface, Inc. | System and method for retrograde procedure |
| US8388624B2 (en) | 2003-02-24 | 2013-03-05 | Arthrosurface Incorporated | Trochlear resurfacing system and method |
| EP1845890A4 (en) | 2003-11-20 | 2010-06-09 | Arthrosurface Inc | System and method for retrograde procedure |
| AU2005260590A1 (en) | 2004-06-28 | 2006-01-12 | Arthrosurface, Inc. | System for articular surface replacement |
| US7828853B2 (en) | 2004-11-22 | 2010-11-09 | Arthrosurface, Inc. | Articular surface implant and delivery system |
| EP2136717B1 (en) | 2006-12-11 | 2013-10-16 | Arthrosurface Incorporated | Retrograde resection apparatus |
| US8980425B2 (en) * | 2007-08-20 | 2015-03-17 | Smith & Nephew Plc | Bioactive material |
| US8470387B2 (en) * | 2008-06-03 | 2013-06-25 | Advanced Medix Inc. | Bone repair material and method for producing the same |
| GB2479514A (en) * | 2009-02-23 | 2011-10-12 | Arthrosurface Inc | Nanorough alloy substrate |
| CA3064646C (en) | 2009-04-17 | 2023-01-03 | Arthrosurface Incorporated | Glenoid resurfacing system and method |
| WO2016154393A1 (en) | 2009-04-17 | 2016-09-29 | Arthrosurface Incorporated | Glenoid repair system and methods of use thereof |
| US9662126B2 (en) | 2009-04-17 | 2017-05-30 | Arthrosurface Incorporated | Glenoid resurfacing system and method |
| WO2011109836A1 (en) | 2010-03-05 | 2011-09-09 | Arthrosurface Incorporated | Tibial resurfacing system and method |
| US8641418B2 (en) | 2010-03-29 | 2014-02-04 | Biomet 3I, Llc | Titanium nano-scale etching on an implant surface |
| US9066716B2 (en) | 2011-03-30 | 2015-06-30 | Arthrosurface Incorporated | Suture coil and suture sheath for tissue repair |
| CA2838017C (en) * | 2011-06-03 | 2019-08-27 | DePuy Synthes Products, LLC | Multilayered valve metal coating for a surgical implant |
| FR2982619A1 (en) | 2011-11-14 | 2013-05-17 | Obl | METHOD FOR SURFACE TREATMENT OF TITANIUM BONE IMPLANTS USING SODIUM HYDROXIDE BATH TO IMPROVE OSTEOINTEGRATION |
| US20130165982A1 (en) | 2011-12-22 | 2013-06-27 | Arthrosurface Incorporated | System and Method for Bone Fixation |
| WO2013142118A1 (en) | 2012-03-20 | 2013-09-26 | Biomet 3I, Llc | Surface treatment for an implant surface |
| EP2641621A1 (en) * | 2012-03-23 | 2013-09-25 | Elos Medtech Pinol A/S | Strontium based coating for body implants |
| DE112013003358T5 (en) | 2012-07-03 | 2015-03-19 | Arthrosurface, Inc. | System and procedure for joint surface replacement and repair |
| WO2014027612A1 (en) * | 2012-08-16 | 2014-02-20 | 学校法人中部大学 | Bone repair material and production method therefor |
| US9492200B2 (en) | 2013-04-16 | 2016-11-15 | Arthrosurface Incorporated | Suture system and method |
| US10251730B2 (en) | 2014-02-21 | 2019-04-09 | Implant And Tissue Engineering Dental Network-Tokyo, Limited Co | Implant body |
| US10624748B2 (en) | 2014-03-07 | 2020-04-21 | Arthrosurface Incorporated | System and method for repairing articular surfaces |
| US9931219B2 (en) | 2014-03-07 | 2018-04-03 | Arthrosurface Incorporated | Implant and anchor assembly |
| US11607319B2 (en) | 2014-03-07 | 2023-03-21 | Arthrosurface Incorporated | System and method for repairing articular surfaces |
| US10537661B2 (en) | 2017-03-28 | 2020-01-21 | DePuy Synthes Products, Inc. | Orthopedic implant having a crystalline calcium phosphate coating and methods for making the same |
| US10537658B2 (en) | 2017-03-28 | 2020-01-21 | DePuy Synthes Products, Inc. | Orthopedic implant having a crystalline gallium-containing hydroxyapatite coating and methods for making the same |
| CA3108761A1 (en) | 2017-08-04 | 2019-02-07 | Arthrosurface Incorporated | Multicomponent articular surface implant |
| EP3687311A1 (en) | 2017-09-27 | 2020-08-05 | Symrise AG | Amides for generating a trigeminal effect |
| WO2020186099A1 (en) | 2019-03-12 | 2020-09-17 | Arthrosurface Incorporated | Humeral and glenoid articular surface implant systems and methods |
| JP7403793B2 (en) * | 2019-11-20 | 2023-12-25 | 公立大学法人公立諏訪東京理科大学 | bone fixator |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2661451B2 (en) * | 1992-02-14 | 1997-10-08 | 株式会社ニコン | Implant and method of manufacturing the same |
| PT678300E (en) | 1993-11-09 | 2000-11-30 | Foudation For The Promotion Of | MATERIAL FOR THE REPLACEMENT OF BONES AND PROCESS FOR THEIR PRODUCTION |
| JP2775523B2 (en) | 1993-11-09 | 1998-07-16 | 財団法人イオン工学振興財団 | Bone substitute material and its manufacturing method |
| US5509633A (en) * | 1994-12-19 | 1996-04-23 | General Motors Corporation | Removable and adjustable cup holder for a vehicle |
| JPH08257109A (en) | 1995-03-28 | 1996-10-08 | Nikon Corp | Intraosseous implant and manufacturing method thereof |
| US6832735B2 (en) * | 2002-01-03 | 2004-12-21 | Nanoproducts Corporation | Post-processed nanoscale powders and method for such post-processing |
| JP2000210313A (en) * | 1999-01-20 | 2000-08-02 | Kobe Steel Ltd | Bone substitutive material having excellent bioaffinity |
| US6183255B1 (en) * | 2000-03-27 | 2001-02-06 | Yoshiki Oshida | Titanium material implants |
| US20030059742A1 (en) | 2001-09-24 | 2003-03-27 | Webster Thomas J. | Osteointegration device and method |
| SE525236C2 (en) * | 2002-10-31 | 2005-01-11 | Cerbio Tech Ab | Process for making structured ceramic coatings and coated devices made with this process |
| US7645439B2 (en) * | 2003-10-10 | 2010-01-12 | Instituto Mexicano Del Petroleo | Nanostructured titanium oxide material and its synthesis procedure |
| US20060229715A1 (en) | 2005-03-29 | 2006-10-12 | Sdgi Holdings, Inc. | Implants incorporating nanotubes and methods for producing the same |
| KR100611945B1 (en) * | 2005-10-04 | 2006-08-11 | 주식회사 메가젠 | Surface treatment method of implant using electrolyte solution for implant surface treatment and implant manufactured by the surface treatment method |
| US8980425B2 (en) * | 2007-08-20 | 2015-03-17 | Smith & Nephew Plc | Bioactive material |
-
2008
- 2008-08-19 US US12/674,236 patent/US8980425B2/en active Active
- 2008-08-19 AT AT08788378T patent/ATE538816T1/en active
- 2008-08-19 AU AU2008290373A patent/AU2008290373B2/en not_active Ceased
- 2008-08-19 ES ES08788378T patent/ES2379304T3/en active Active
- 2008-08-19 CA CA2696954A patent/CA2696954C/en not_active Expired - Fee Related
- 2008-08-19 JP JP2010521471A patent/JP6165408B2/en active Active
- 2008-08-19 WO PCT/GB2008/002814 patent/WO2009024778A2/en not_active Ceased
- 2008-08-19 EP EP20080788378 patent/EP2200669B1/en not_active Not-in-force
-
2015
- 2015-01-13 US US14/595,837 patent/US20150165089A1/en not_active Abandoned
-
2016
- 2016-08-15 JP JP2016159145A patent/JP6466377B2/en not_active Expired - Fee Related
-
2017
- 2017-08-18 US US15/680,757 patent/US20180014936A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2008290373B2 (en) | 2014-08-28 |
| EP2200669A2 (en) | 2010-06-30 |
| EP2200669B1 (en) | 2011-12-28 |
| CA2696954C (en) | 2016-09-13 |
| JP6466377B2 (en) | 2019-02-06 |
| ES2379304T3 (en) | 2012-04-24 |
| US20110059312A1 (en) | 2011-03-10 |
| JP2016190092A (en) | 2016-11-10 |
| JP6165408B2 (en) | 2017-07-19 |
| US20150165089A1 (en) | 2015-06-18 |
| US8980425B2 (en) | 2015-03-17 |
| CA2696954A1 (en) | 2009-02-26 |
| JP2010536451A (en) | 2010-12-02 |
| WO2009024778A2 (en) | 2009-02-26 |
| WO2009024778A3 (en) | 2010-03-25 |
| HK1145816A1 (en) | 2011-05-06 |
| AU2008290373A1 (en) | 2009-02-26 |
| ATE538816T1 (en) | 2012-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8980425B2 (en) | Bioactive material | |
| US20040167632A1 (en) | Metallic implants having roughened surfaces and methods for producing the same | |
| CN105965154B (en) | A kind of biomedical titanium surface modifying method | |
| Lee et al. | Effect of surface structure on biomechanical properties and osseointegration | |
| US11058794B2 (en) | Method for surface treatment of a biocompatible metal material and implant treated by said method | |
| US7981461B2 (en) | Metallic bone implant having improved implantability and method of making the same | |
| Shi et al. | Effects of hydrothermal sterilization on properties of biological coating fabricated by alkaline-heat treatment on titanium | |
| Fatehi et al. | Biomimetic hydroxyapatite coatings deposited onto heat and alkali treated Ti6Al4V surface | |
| AU2014268254B2 (en) | Bioactive material | |
| Spriano et al. | Characterization of surface modified Ti-6Al-7Nb alloy | |
| HK1145816B (en) | Method of forming a bioactive implant material | |
| Xie et al. | Novel hydroxyapatite coating on new porous titanium and titanium-HDPE composite for hip implant | |
| US11883556B2 (en) | Method for surface treatment of a bio-compatible metal material and implant treated by said method | |
| Melo-Soares et al. | Effect of surface pre-treatment with Er: YAG laser on hydroxyapatite coating adhesion and mechanical properties of titanium alloy discs | |
| Wang et al. | Effect of substrate oxidation on improving the quality of hydroxyapatite coating on CoNiCrMo | |
| KR102486628B1 (en) | Surface Treatment Composition for Dental Implant and Surface Treatment Methods Using Thereof | |
| Chauhan et al. | Critical Role of Etching Parameters in the Evolution of Nano Micro SLA Surface on the Ti6Al4V Alloy Dental Implants. Materials 2021, 14, 6344 | |
| Calvert et al. | Advances in calcium phosphate coatings--anodic spark deposition: A review | |
| Kang | On the Bone Tissue Response to Surface Chemistry Modifications of Titanium Implants | |
| FRSA et al. | Controlled Laser Texturing of Titanium Results in Reliable Osteointegration | |
| CZ2014944A3 (en) | Joint implant and process for producing thereof | |
| Wang | Surface modification of zirconium implants via electrochemical anodization and wet chemical techniques | |
| Kesarwani | Alkali treatment of Ti6Al4V alloy and it’s effect on bio-activity | |
| Kokubo et al. | BIOACTIVE HA COATINGS BY TI SURFACE ACTIVATION | |
| Mediaswanti | Fabrication and surface modifications of titanium alloys for bone implant applications |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: SMITH & NEPHEW UK LIMITED, ENGLAND Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HOWLING, GRAEME;GUNNING, PAUL;REEL/FRAME:043335/0966 Effective date: 20101210 |
|
| AS | Assignment |
Owner name: SMITH & NEPHEW PLC, UNITED KINGDOM Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SMITH & NEPHEW UK LIMITED;REEL/FRAME:043367/0728 Effective date: 20101012 |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |